Integral Ebitda from 2010 to 2024

Stocks . Australia . 
Stock . Integral Diagnostics
IDX Stock   2.91  0.01  0.34%   
Integral Diagnostics EBITDA yearly trend continues to be comparatively stable with very little volatility. EBITDA will likely drop to about 11.7 M in 2024. From the period from 2010 to 2024, Integral Diagnostics EBITDA quarterly data regression had r-value of  0.57 and coefficient of variation of  91.64. View All Fundamentals
 
EBITDA  
First Reported
2014-12-31
Previous Quarter
-31.4 M
Current Value
46.8 M
Quarterly Volatility
16.6 M
 
Yuan Drop
 
Covid
Check Integral Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integral Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 23.4 M, Total Revenue of 238.8 M or Operating Income of 5.1 M, as well as many indicators such as . Integral financial statements analysis is a perfect complement when working with Integral Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Integral Diagnostics Technical models . Check out the analysis of Integral Diagnostics Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Integral Stock Analysis

When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY